Area of research
Oncology · Pharmacology
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Pharmacogenetics and Drug Metabolism, Epigenetics and DNA Methylation, and Cancer Genomics and Diagnostics.
Alterations in homologous recombination repair genes in prostate cancer brain metastases
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
Rs895819 in <scp><i>MIR27A</i></scp> improves the predictive value of <scp><i>DPYD</i></scp> variants to identify patients at risk of severe fluoropyrimidine‐associated toxicity
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer